{"id":5652,"date":"2026-11-10T07:44:12","date_gmt":"2026-11-10T07:44:12","guid":{"rendered":"https:\/\/nhdbio.com\/?p=5652"},"modified":"2026-11-10T07:57:15","modified_gmt":"2026-11-10T07:57:15","slug":"survodutide-mash-liver-fat-inflammation-fibrosis-explained","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/pt-br\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/","title":{"rendered":"Estudo hep\u00e1tico com Survodutide: o que gordura hep\u00e1tica, inflama\u00e7\u00e3o e fibrose avaliam separadamente"},"content":{"rendered":"<section class=\"nhd-cp-topic\" id=\"nhd-cp-topic-knowledge-20261110-01\" style=\"max-width:1200px;margin:32px auto;padding:0 20px\">\n<h2>Survodutide and MASH: Reading Liver Fat and Fibrosis Results<\/h2>\n<p class=\"nhd-cp-lead\">A fatty liver study may report liver fat reduction, improvement in liver inflammation and fibrosis change at the same time. All three relate to the liver, but they are not the same outcome. Below, a 48-week trial is used to separate these three things clearly.<\/p>\n<figure style=\"margin:28px 0\"><img decoding=\"async\" src=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-covers-cover-01.png\" alt=\"Survodutide and MASH: Reading Liver Fat and Fibrosis Results\" width=\"1536\" height=\"1024\" loading=\"lazy\" style=\"display:block;width:100%;height:auto;object-fit:contain;border-radius:14px\"><figcaption>Editorial illustration of the research topic, not an experimental photograph.<\/figcaption><\/figure>\n<h3>Start with three terms<\/h3>\n<p>Liver fat is how much fat is in the liver; inflammation and liver cell injury are signs that the tissue is affected; fibrosis involves the buildup of scar-like tissue. You can think of them as clutter piling up in a room, damage that is currently happening, and marks left after damage. This analogy only helps understanding; the three do not have a fixed one-to-one correspondence. Imaging results that check liver fat cannot directly replace histological judgment of inflammation and fibrosis.<\/p>\n<h3>How the trial compared groups<\/h3>\n<p>The phase 2 Survodutide study published in 2024 enrolled adults with biopsy-confirmed MASH and fibrosis stage F1 to F3, compared three study dose groups with placebo, and followed participants for 48 weeks. A total of 293 randomized participants received at least one dose of study treatment. The primary endpoint was histological improvement in MASH with no worsening of fibrosis. Here, &quot;no worsening&quot; does not mean &quot;already reversed.&quot; This article reviews that published study, not new approval news from 2026. <a href=\"#knowledge-20261110-01-source-1\">[1]<\/a><\/p>\n<figure style=\"margin:28px 0\"><img decoding=\"async\" class=\"nhd-localized-figure\" src=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-figures-01-en_US.png\" data-nhd-img-zh=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-figures-01-zh_CN.png\" data-nhd-img-en=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-figures-01-en_US.png\" data-nhd-img-de=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-figures-01-de_DE.png\" data-nhd-img-es=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-figures-01-es_ES.png\" data-nhd-img-fr=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-figures-01-fr_FR.png\" data-nhd-img-pt=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-figures-01-pt_BR.png\" data-nhd-img-ja=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-figures-01-ja.png\" data-nhd-img-ar=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-figures-01-ar.png\" alt=\"Understanding the three outcomes in a liver study\" loading=\"lazy\" width=\"1600\" height=\"1500\" style=\"width:100%;height:auto;object-fit:contain;display:block\"><figcaption>Numbers come from the corresponding analyses in the 2024 48-week phase 2 paper; different endpoints cannot be mixed into the same percentage.<\/figcaption><\/figure>\n<details>\n<summary>Understanding the three outcomes in a liver study<\/summary>\n<ul>\n<li><strong>Liver fat change<\/strong>: Change in fat content; cannot replace histological judgment<\/li>\n<li><strong>MASH histological improvement without fibrosis worsening<\/strong>: Primary endpoint; middle-dose group 62%, placebo 14%<\/li>\n<li><strong>Fibrosis improvement of at least one stage<\/strong>: Another outcome; middle-dose group 36%, placebo 22%<\/li>\n<\/ul>\n<\/details>\n<h3>Which outcome does the 62% figure correspond to<\/h3>\n<p>In the paper&#039;s primary analysis, the proportions of participants reaching the primary endpoint in the three Survodutide groups were 47%, 62% and 43%, respectively, versus 14% in the placebo group. The 62% is the proportion of participants in one study group who met the specified composite condition; it is not a 62% reduction in liver fat for every participant, nor does it mean the liver recovered by 62%. The corresponding group, analysis population and rules for handling missing biopsies must be kept together with the number. The proportions also did not simply rise steadily as the dose increased. <a href=\"#knowledge-20261110-01-source-1\">[1]<\/a><\/p>\n<h3>Two other tables answer different questions<\/h3>\n<p>The paper also reported the proportion of participants with at least 30% reduction in liver fat and the proportion with fibrosis improvement of at least one stage. For the middle-dose group, for example, these two proportions were 67% and 36%, respectively; in the placebo group they were 14% and 22%. Their judgment criteria and measurement methods differ, so 67%, 62% and 36% cannot be lined up as the same kind of &quot;efficacy ranking.&quot; Secondary endpoints should also be read together with the limitations of multiple comparisons and statistical analysis, not by picking only the largest number. <a href=\"#knowledge-20261110-01-source-1\">[1]<\/a><\/p>\n<h3>Look at adverse events on the same page<\/h3>\n<p>The paper reported that in the pooled Survodutide groups, the proportions of nausea, diarrhea and vomiting were higher than in the placebo group: 66% vs 23%, 49% vs 23%, and 41% vs 4%, respectively. These numbers come from the treatment and observation conditions of this study, not from safety testing of catalog materials. When evaluating a study, benefits, tolerability, discontinuation, analysis methods and follow-up time should be considered together; this article does not provide medication or dosing advice. <a href=\"#knowledge-20261110-01-source-1\">[1]<\/a><\/p>\n<h3>How to bring the paper&#039;s questions into material procurement<\/h3>\n<p>First state clearly that the study object is Survodutide, then confirm the specific form, specification, quantity and analytical documentation needed. The clinical formulation in the paper does not automatically equal any catalog material with the same name. When requesting a quote, you can say: &quot;I need Survodutide material for experimental research; please confirm the supply form, corresponding specification and available batch documentation.&quot; The product page is responsible for material information, and the original paper is responsible for clinical study results; the two records should be kept separately.<\/p>\n<h3>Original sources<\/h3>\n<ol class=\"nhd-cp-source\">\n<li id=\"knowledge-20261110-01-source-1\"><a href=\"https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2401755\" target=\"_blank\" rel=\"noopener noreferrer\">Survodutide \u00b7 NEJM \u00b7 2024 \u00b7 DOI 10.1056\/NEJMoa2401755<\/a><\/li>\n<\/ol>\n<p class=\"nhd-cp-source\">Check the study conditions and material records separately. Calculations labeled as examples are not batch test results.<\/p>\n<h3>Related research materials<\/h3>\n<div class=\"nhd-cp-products\" style=\"display:grid;grid-template-columns:repeat(auto-fit,minmax(min(100%,240px),1fr));gap:20px\"><a class=\"nhd-cp-product\" href=\"https:\/\/nhdbio.com\/products\/survodutide\/\" style=\"display:block;border:1px solid #dce4ed;border-radius:14px;padding:24px;background:#f7f9fb;color:#102b49\"><img decoding=\"async\" src=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/product-family-mockups\/survodutide-product-family-mockup-20260828.webp\" alt=\"Survodutide\" width=\"1536\" height=\"1024\" loading=\"lazy\" style=\"width:100%;height:auto;max-height:200px;object-fit:contain;display:block;margin:0 auto 16px\"><strong style=\"display:block;font-size:22px;margin-bottom:10px\">Survodutide<\/strong><span>View product information and specifications \u2192<\/span><\/a><\/div>\n<p><a class=\"nhd-cp-download\" href=\"https:\/\/nhdbio.com\/quote\/\">Enquire about products and information \u2192<\/a><\/p>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Um estudo sobre f\u00edgado gorduroso pode apresentar ao mesmo tempo redu\u00e7\u00e3o da gordura hep\u00e1tica, melhora da inflama\u00e7\u00e3o do f\u00edgado e altera\u00e7\u00f5es na fibrose. Todos esses pontos se relacionam ao f\u00edgado, mas n\u00e3o s\u00e3o o mesmo resultado. A seguir, um ensaio de 48 semanas separa e esclarece essas tr\u00eas coisas.<\/p>","protected":false},"author":1,"featured_media":5449,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"365","pim_article_type":"Published research explained","pim_evidence_level":"Published clinical trial","pim_reviewer":"AI-assisted source and editorial check","pim_reviewed_date":"2026-11-10","pim_editorial_note":"Editorial illustrations are not experimental photographs. Teaching values are labeled.","pim_review_status":"reviewed","pim_review_reason":"Reviewed source scope, numerical examples, natural Chinese, product links and content layout.","pim_creation_method":"AI-assisted writing","pim_sources":"[{\"title\":\"Survodutide \u00b7 NEJM \u00b7 2024 \u00b7 DOI 10.1056\/NEJMoa2401755\",\"note\":\"Survodutide \u00b7 NEJM \u00b7 2024 \u00b7 DOI 10.1056\/NEJMoa2401755\",\"url\":\"https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2401755\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-5652","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Survodutide and MASH: Reading Liver Fat and Fibrosis Results<\/title>\n<meta name=\"description\" content=\"Read the 48-week Survodutide MASH trial: what the liver-fat, inflammation and fibrosis results mean, with original data and research-material links.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/pt-br\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Survodutide and MASH: Reading Liver Fat and Fibrosis Results\" \/>\n<meta property=\"og:description\" content=\"Read the 48-week Survodutide MASH trial: what the liver-fat, inflammation and fibrosis results mean, with original data and research-material links.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/pt-br\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-10T07:44:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-10T07:57:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-covers-cover-01-1024x683.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Estudo hep\u00e1tico com Survodutide: o que gordura hep\u00e1tica, inflama\u00e7\u00e3o e fibrose avaliam separadamente\",\"datePublished\":\"2026-11-10T07:44:12+00:00\",\"dateModified\":\"2026-11-10T07:57:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\\\/\"},\"wordCount\":713,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/nhd-20261110-covers-cover-01.png\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\\\/\",\"name\":\"Survodutide and MASH: Reading Liver Fat and Fibrosis Results\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/nhd-20261110-covers-cover-01.png\",\"datePublished\":\"2026-11-10T07:44:12+00:00\",\"dateModified\":\"2026-11-10T07:57:15+00:00\",\"description\":\"Read the 48-week Survodutide MASH trial: what the liver-fat, inflammation and fibrosis results mean, with original data and research-material links.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/nhd-20261110-covers-cover-01.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/nhd-20261110-covers-cover-01.png\",\"width\":1536,\"height\":1024,\"caption\":\"Survodutide and MASH: Reading Liver Fat and Fibrosis Results\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Survodutide and MASH: Reading Liver Fat and Fibrosis Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/pt-br\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Survodutide e MASH: como interpretar os resultados de gordura hep\u00e1tica e fibrose","description":"Read the 48-week Survodutide MASH trial: what the liver-fat, inflammation and fibrosis results mean, with original data and research-material links.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/pt-br\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/","og_locale":"pt_BR","og_type":"article","og_title":"Survodutide and MASH: Reading Liver Fat and Fibrosis Results","og_description":"Read the 48-week Survodutide MASH trial: what the liver-fat, inflammation and fibrosis results mean, with original data and research-material links.","og_url":"https:\/\/nhdbio.com\/pt-br\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/","og_site_name":"NHD","article_published_time":"2026-11-10T07:44:12+00:00","article_modified_time":"2026-11-10T07:57:15+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-covers-cover-01-1024x683.png","type":"image\/png"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Estudo hep\u00e1tico com Survodutide: o que gordura hep\u00e1tica, inflama\u00e7\u00e3o e fibrose avaliam separadamente","datePublished":"2026-11-10T07:44:12+00:00","dateModified":"2026-11-10T07:57:15+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/"},"wordCount":713,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-covers-cover-01.png","articleSection":["Published Study Reviews"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/","url":"https:\/\/nhdbio.com\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/","name":"Survodutide e MASH: como interpretar os resultados de gordura hep\u00e1tica e fibrose","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-covers-cover-01.png","datePublished":"2026-11-10T07:44:12+00:00","dateModified":"2026-11-10T07:57:15+00:00","description":"Read the 48-week Survodutide MASH trial: what the liver-fat, inflammation and fibrosis results mean, with original data and research-material links.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-covers-cover-01.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/11\/nhd-20261110-covers-cover-01.png","width":1536,"height":1024,"caption":"Survodutide and MASH: Reading Liver Fat and Fibrosis Results"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/survodutide-mash-liver-fat-inflammation-fibrosis-explained\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Survodutide and MASH: Reading Liver Fat and Fibrosis Results"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mat\u00e9rias-primas pept\u00eddicas e s\u00edntese personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipe t\u00e9cnica NHD","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"A equipe t\u00e9cnica NHD mant\u00e9m documenta\u00e7\u00e3o de cat\u00e1logo de uso em pesquisa e resumos de evid\u00eancias. Os artigos revisados \u200b\u200bvinculam-se a artigos revisados \u200b\u200bpor pares, registros de ensaios e registros regulat\u00f3rios, ret\u00eam resultados nulos e limita\u00e7\u00f5es de estudos e distinguem interven\u00e7\u00f5es publicadas de materiais de cat\u00e1logo. O desenho assistido por AI pode ser usado para estrutura; os links de origem e os limites das evid\u00eancias permanecem vis\u00edveis. Este trabalho n\u00e3o \u00e9 uma revis\u00e3o independente por pares ou aconselhamento m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/pt-br\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/5652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/comments?post=5652"}],"version-history":[{"count":6,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/5652\/revisions"}],"predecessor-version":[{"id":5763,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/5652\/revisions\/5763"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media\/5449"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media?parent=5652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/categories?post=5652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/tags?post=5652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}